Misuse of Drugs Act 1971

Section 2.

SCHEDULE 2 U.K. Controlled Drugs

Part I U.K. Class A Drugs

1 U.K. The following substances and products, namely:—

[F1 (a)]

• Acetorphine.

• [F2 Alfentanil.]

• Allylprodine.

• Alphacetylmethadol.

• Alphameprodine.

• Alphamethadol.

• Alphaprodine.

• Anileridine.

• Benzethidine.

• Benzylmorphine (3-benzylmorphine).

• Betacetylmethadol.

• Betameprodine.

• Betamethadol.

• Betaprodine.

• Bezitramide.

• Bufotenine.

• F3 ...

• F4 ...

• [F5 Carfentanil.]

• Clonitazene.

• Coca leaf.

• Cocaine.

• Desomorphine.

• Dextromoramide.

• Diamorphine.

• Diampromide.

• Diethylthiambutene.

• [F6 Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid).]

• DihydrocodeinoneO-carboxymethyloxime.

• [F7 Dihydroetorphine]

• Dimenoxadole.

• Dimepheptanol.

• Dimethylthiambutene.

• Dioxaphetyl butyrate.

• Diphenoxylate.

• Dipipanone.

• [F8 Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol).]

• Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine.

• Ethylmethylthiambutene.

• [F2 Eticyclidine.]

• Etonitazene.

• Etorphine.

• Etoxeridine.

• [F9 Etryptamine]

• Fentanyl.

• [F10 Fungus (of any kind) which contains psilocin or an ester of psilocin.]

• Furethidine.

• Hydrocodone.

• Hydromorphinol.

• Hydromorphone.

• Hydroxypethidine.

• Isomethadone.

• Ketobemidone.

• Levomethorphan.

• Levomoramide.

• Levophenacylmorphan.

• Levorphanol.

• [F5 Lofentanil]

• Lysergamide.

• Lysergide and otherN-alkyl derivatives of lysergamide.

• Mescaline.

• Metazocine.

• Methadone.

• Methadyl acetate.

• [F11 Methylamphetamine]

• Methyldesorphine.

• Methyldihydromorphine (6-methyldihydromorphine).

• Metopon.

• Morpheridine.

• Morphine.

• Morphine methobromide, morphineN-oxide and other pentavalent nitrogen morphine derivatives.

• Myrophine.

• F12 . . .

• Nicomorphine (3,6-dinicotinoylmorphine).

• Noracymethadol.

• Norlevorphanol.

• Normethadone.

• Normorphine.

• Norpipanone.

• Opium, whether raw, prepared or medicinal.

• Oxycodone.

• Oxymorphone.

• Pethidine.

• Phenadoxone.

• Phenampromide.

• Phenazocine.

• [F13 Phencyclidine.]

• Phenomorphan.

• Phenoperidine.

• Piminodine.

• Piritramide.

• Poppy-straw and concentrate of poppy-straw.

• Proheptazine.

• Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester).

• Psilocin.

• Racemethorphan.

• Racemoramide.

• Racemorphan.

• [F14 Remifentanil]

• [F2 Rolicyclidine.]

• [F15 Sufentanil.]

• [F2 Tenocylidine.]

• Thebacon.

• Thebaine.

• [F15 Tilidate.]

• Trimeperidine.

• [F16 4-Bromo-2,5-dimethoxy-a-methylphenethylamine].

• 4-Cyano-2-dimethylamino-4,4-diphenylbutane.

• 4-Cyano-1-methyl-4-phenyl-piperidine.

• N,N-Diethyltryptamine.

• N,N-Dimethyltryptamine.

• 2,5-Dimethoxy-a,4-dimethylphenethylamine.

• [F17 N-Hydroxy-tenamphetamine.]

• 1-Methyl-4-phenylpiperidine-4-carboxylic acid.

• 2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid.

• [F18 4-Methyl-aminorex]

• 4-Phenylpiperidine-4-carboxylic acid ethyl ester.

[F19 (b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

[F20 (ba) the following phenethylamine derivatives, namely:—

• Allyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol

• 2-Amino-1-(3,4-dimethoxyphenyl)ethanol

• Benzyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• 4-Bromo- b ,2,5-trimethoxyphenethylamine

• N -(4- sec -Butylthio-2,5-dimethoxyphenethyl)hydroxylamine

• Cyclopropylmethyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• 2-(4,7-Dimethoxy-2,3-dihydro-1 H -indan-5-yl)ethylamine

• 2-(4,7-Dimethoxy-2,3-dihydro-1 H -indan-5-yl)-1-methylethylamine

• 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine

• 2-(1,4-Dimethoxy-2-naphthyl)ethylamine

• 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine

• N -(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine

• 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine

• 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine

• a , a -Dimethyl-3,4-methylenedioxyphenethylamine

• a , a -Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine

• Dimethyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• N -(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine

• 4-Iodo-2,5-dimethoxy- a -methylphenethyl(dimethyl)amine

• 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine

• 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine

• 2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[ b ]furan-6-yl)-1-methylethylamine

• 2-Methoxyethyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• 2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[ b ]furan-6-yl)-1-methylethylamine

• b -Methoxy-3,4-methylenedioxyphenethylamine

• 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine

• 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine

• 2-( a -Methyl-3,4-methylenedioxyphenethylamino)ethanol

• a -Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine

• N -Methyl- N -( a -methyl-3,4-methylenedioxyphenethyl)hydroxylamine

• O -Methyl- N -( a -methyl-3,4-methylenedioxyphenethyl)hydroxylamine

• a -Methyl-4-(methylthio)phenethylamine

• b ,3,4,5-Tetramethoxyphenethylamine

• b ,2,5-Trimethoxy-4-methylphenethylamine; ]

(c) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine an N -alkylphenethylamine,a-methylphenethylamine, an N -alkyl-a-methylphenethylamine,a-ethylphenethylamine, or an N -alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents. ]

[F21 (d) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,

(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi) by replacement of the N-propionyl group by another acyl group;

(e) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,

(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii) by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v) by formation of an N-oxide or of a quaternary base.]

Textual Amendments

F1 "(a)" inserted by S.I. 1977/1243, art. 3(a)

F2 Word inserted by S.I. 1984/859, art. 2(2)

F3 Words in Sch. 2 Pt. 1 para. 1(a) deleted (29.1.2004) by The Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003 (S.I. 2003/3201), art. 2(2)

F4 Words in Sch. 2 Pt. 1 para. 1(a) deleted (29.1.2004) by The Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003 (S.I. 2003/3201), art. 2(2)

F5 Word inserted by S.I. 1986/2230, art. 2(2)(a)

F6 Word inserted by S.I. 1975/421, art. 3

F7 Word in Sch. 2 Pt. 1 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), art. 2(2)(a)

F8 Word inserted by S.I. 1973/771, art. 2

F9 Word in Sch. 2 Pt. I para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(2)

F10 Words in Sch. 2 Pt. 1 para. 1 inserted (18.7.2005) by Drugs Act 2005 (c. 17), s. 21

F11 Word in Sch. 2 Pt. 1 para. 1(a) inserted (18.1.2007) by The Misuse of Drugs Act 1971 (Amendment) Order 2006 (S.I. 2006/3331), art. 2(1)

F12 Words repealed by S.I. 1973/771, art. 2

F13 Word inserted by S.I. 1979/299, art. 2

F14 Word in Sch. 2 Pt. 1 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), art. 2(2)(b)

F15 Word inserted by S.I. 1983/765, art. 2(a)

F16 Words inserted by S.I. 1975/421, art. 3

F17 Word inserted by S.I. 1990/2589, art. 2(a)(i)

F18 Word inserted by S.I. 1990/2589, art. 2(a)(ii)

F19 Sch. 2 Pt. I para. 1(b)(c) added by S.I. 1977/1243, art. 3(b)

F20 Sch. 2 Pt. I para. 1(ba) inserted (1.2.2002) by The Misuse of Drugs Act 1971 (Modification) Order 2001 (S.I. 2001/3932), art. 2(2)

F21 Sch. 2 Pt. I para. 1(d)(e) added by S.I. 1986/2230, art. 2(2)(b)

2 U.K. Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan.

3 U.K. Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above [F22 not being a substance for the time being specified in Part II of this Schedule].

Textual Amendments

F22 Words inserted by S.I. 1973/771, art. 2

4 U.K. Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above.

5 U.K. Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above.

6 U.K. Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.

Part II U.K. Class B Drugs

1 U.K. The following substances and products, namely:—

[F23 (a)]

• Acetyldihydrocodeine.

• Amphetamine.

• [F24 Cannabinol]

• [F24 Cannabinol derivatives]

• [F24 Cannabis and cannabis resin]

• F25 ...

• Codeine.

• F26 . . .

• Dihydrocodeine.

• Ethylmorphine (3-ethylmorphine).

• [F27 Glutethimide.]

• [F27 Lefetamine.]

• [F28 Mecloqualone.]

• [F28 Methaqualone.]

• [F29 Methcathinone]

• [F30 4–Methylmethcathinone]

• F31 ...

• [F32 a-Methylphenethylhydroxylamine]

• Methylphenidate.

• [F28 Methylphenobarbitone.]

• Nicocodine.

• [F33 Nicodicodine (6-nicotinoyldihydrocodeine).]

• Norcodeine.

• [F34 Pentazocine.]

• Phenmetrazine.

• Pholcodine.

• [F35 Propiram.]

• [F29 Zipeprol]

[F36 (aa) Any compound (not being bupropion, cathinone, diethylpropion, pyrovalerone or a compound for the time being specified in sub–paragraph (a) above) structurally derived from 2–amino–1–phenyl–1–propanone by modification in any of the following ways, that is to say,

(i) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;

(ii) by substitution at the 3–position with an alkyl substituent;

(iii) by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.]

[F37 (ab) Any compound structurally derived from 2–aminopropan–1–one by substitution at the 1-position with any monocyclic, or fused‑polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the compound is further modified in any of the following ways, that is to say,

(i) by substitution in the ring system to any extent with alkyl, alkoxy, haloalkyl or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;

(ii) by substitution at the 3–position with an alkyl substituent;

(iii) by substitution at the 2‑amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2‑amino nitrogen atom in a cyclic structure.]

[F23 (b) any 5,5 disubstituted barbituric acid.]

[F38 (c) [2,3–Dihydro–5–methyl–3–(4–morpholinylmethyl)pyrrolo[1, 2, 3–de]–1,4–benzoxazin–6–yl]–1–naphthalenylmethanone.

3–Dimethylheptyl–11–hydroxyhexahydrocannabinol.

[9–Hydroxy–6–methyl–3–[5–phenylpentan–2–yl] oxy–5, 6, 6a, 7, 8, 9, 10, 10a–octahydrophenanthridin–1–yl] acetate.

9-(Hydroxymethyl)–6, 6–dimethyl–3–(2–methyloctan–2–yl)–6a, 7, 10, 10a–tetrahydrobenzo[c]chromen–1–ol.

Nabilone.

• Any compound structurally derived from 3–(1–naphthoyl)indole or 1H–indol–3–yl–(1–naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

• Any compound structurally derived from 3–(1–naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

• Any compound structurally derived from 1–(1–naphthylmethyl)indene by substitution at the 3–position of the indene ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.

• Any compound structurally derived from 3–phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.

• Any compound structurally derived from 2–(3–hydroxycyclohexyl)phenol by substitution at the 5–position of the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the cyclohexyl ring to any extent.]

Textual Amendments

F23 Sch. 2 Pt. 2 para. 1(b) added by S.I. 1984/859, art. 2(3)

F24 Words in Sch. 2 Pt. 2 para. 1(a) inserted (26.1.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2008 (S.I. 2008/3130), art. 2(2)(a)

F25 Words in Sch. 2 Pt. 2 para. 1(a) deleted (29.1.2004) by The Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003 (S.I. 2003/3201), art. 2(3)

F26 Word repealed by S.I. 1985/1995, art. 2(2)(a)

F27 Word inserted by S.I. 1985/1995, art. 2(2)(b)

F28 Word inserted by S.I. 1984/859, art. 2(3)

F29 Words in Sch. 2 Pt. 2 para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(3)

F30 Word in Sch. 2 Pt. 2 para. 1(a) inserted (16.4.2010) by The Misuse of Drugs Act 1971 (Amendment) Order 2010 (S.I. 2010/1207), art. 2(a)

F31 Word in Sch. 2 Pt. 2 para. 1(a) repealed (18.1.2007) by The Misuse of Drugs Act 1971 (Amendment) Order 2006 (S.I.2006/3331), art. 2(2)

F32 Word in Sch. 2 Pt. 2 para. 1(a) inserted (1.2.2002) by S.I. 2001/3932, art. 2(3)

F33 Words inserted by S.I. 1973/771, art. 2

F34 Word inserted by S.I. 1985/1995, art. 2(2)(c)

F35 Word inserted by S.I. 1973/771, art. 2

F36 Sch. 2 Pt. 2 para. 1(aa) inserted (16.4.2010) by The Misuse of Drugs Act 1971 (Amendment) Order 2010 (S.I. 2010/1207), art. 2(b)

F37 Sch. 2 Pt. 2 para. 1(ab) inserted (23.7.2010) by The Misuse of Drugs Act 1971 (Amendment No. 2) Order 2010 (S.I. 2010/1833), art. 2

F38 Sch. 2 Pt. 2 para. 1(c) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(2)(a)

2 U.K. Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule.

[F39 2A. U.K. Any ester or ether of cannabinol or of a cannabinol derivative [F40 or of a substance for the time being specified in paragraph 1(c) of this Part of this Schedule.] .]

Textual Amendments

F39 Sch. 2 Pt. 2 para. 2A inserted (26.1.2009) by Misuse of Drugs Act 1971 (Amendment) Order 2008 (S.I. 2008/3130), arts. 1(1), 2(2)(b)

F40 Words in Sch. 2 Pt. 2 para. 2A inserted (23.12.2009) by Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), arts. 1, 2(2)(b)

3 U.K. Any salt of a substance for the time being specified in paragraph 1 [F41 , 2 or 2A] of this Part of this Schedule.

Textual Amendments

F41 Words in Sch. 2 Pt. 2 para. 3 substituted ( 26.1.2009 ) by The Misuse of Drugs Act 1971 (Amendment) Order 2008 (S.I. 2008/3130), art. 2(2)(c)

4 U.K. Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.

Part III U.K. Class C Drugs

1 U.K. The following substances, namely:—

• [F43 Alprazolam.]

• [F44 Aminorex]

• Benzphetamine.

• [F43 Bromazepam.]

• [F44 Brotizolam]

• [F45 Buprenorphine]

• [F43 Camazepam.]

• F46 ...

• F47 ...

• F48 ...

• [F49 Cathine.]

• [F49 Cathinone.]

• [F43 Chlordiazepoxide.]

• Chlorphentermine.

• [F43 Clobazam.]

• [F43 Clorazepic acid.]

• [F43 Clonazepam.]

• [F43 Clotiazepam.]

• [F43 Cloxazolam.]

• [F43 Delorazepam.]

• [F50 Dextropropoxyphene.]

• [F43 Diazepam.]

• [F51 Diethylpropion.]

• [F43 Estazolam.]

• [F43 Ethchlorvynol.]

• [F43 Ethinamate.]

• [F43 Ethyl loflazepate.]

• [F49 Fencamfamin.]

• [F49 Fenethylline.]

• [F49 Fenproporex.]

• [F43 Fludiazepam.]

• [F43 Flunitrazepam.]

• [F43 Flurazepam.]

• [F52 Gamma–butyrolactone]

• [F43 Halazepam.]

• [F43 Haloxazolam.]

• [F53 4-Hydroxy-n-butyric acid]

• [F54 Ketamine]

• [F43 Ketazolam.]

• [F43 Loprazolam.]

• [F43 Lorazepam.]

• [F43 Lormetazepam.]

• [F43 Mazindol.]

• [F43 Medazepam.]

• [F49 Mefenorex.]

• F55 . . .

• Mephentermine.

• [F43 Meprobamate.]

• [F44 Mesocarb]

• F56 . . .

• [F43 Methyprylone.]

• [F57 Midazolam.]

• [F43 Nimetazepam.]

• [F43 Nitrazepam.]

• [F43 Nordazepam.]

• [F43 Oxazepam.]

• [F43 Oxazolam.]

• [F58 Pemoline.]

• F55 . . .

• Phendimetrazine.

• [F43 Phentermine.]

• [F43 Pinazepam.]

• F55 . . .

• Pipradrol.

• [F43 Prazepam.]

• F55 . . .

• F59 . . .

• [F49 Pyrovalerone.]

• [F43 Temazepam.]

• [F43 Tetrazepam.]

• [F43 Triazolam.]

• [F49 N-Ethylamphetamine.]

• [F60 Zolpidem]

• [F61 (b) [F62 5α–Androstane–3,17–diol.]

• [F63 Androst-4-ene-3,17-diol.]

• [F64 1–Androstenediol.]

• [F65 1–Androstenedione]

• [F66 4-Androstene-3, 17-dione]

• [F67 5–Androstenedione.]

• [F66 5-Androstene-3, 17-diol]

• Atamestane.

• Bolandiol.

• Bolasterone.

• Bolazine.

• Boldenone.

• [F68 Boldione.]

• Bolenol.

• Bolmantalate.

• [F69 1,4–Butanediol.]

• Calusterone.

• 4-Chloromethandienone.

• Clostebol.

• [F70 Danazol.]

• [F71 Desoxymethyltestosterone]

• Drostanolone.

• Enestebol.

• Epitiostanol.

• Ethyloestrenol.

• Fluoxymesterone.

• Formebolone.

• Furazabol.

• [F72 Gestrinone.]

• [F73 3–Hydroxy–5α–androstan–17–one.]

• Mebolazine.

• Mepitiostane.

• Mesabolone.

• Mestanolone.

• Mesterolone.

• Methandienone.

• Methandriol.

• Methenolone.

• Methyltestosterone.

• Metribolone.

• Mibolerone.

• Nandrolone.

• [F74 19–Norandrostenedione.]

• [F75 19-Nor-4-Androstene-3, 17-dione]

• [F76 19–Norandrosterone.]

• [F75 19-Nor-5-Androstene-3, 17-diol]

• Norboletone.

• Norclostebol.

• Norethandrolone.

• [F77 19–Noretiocholanolone.]

• [F78 Oripavine.]

• Ovandrotone.

• Oxabolone.

• Oxandrolone.

• Oxymesterone.

• Oxymetholone.

• Prasterone.

• Propetandrol.

• [F79 Prostanozol]

• Quinbolone.

• Roxibolone.

• Silandrone.

• Stanolone.

• Stanozolol.

• Stenbolone.

• Testosterone.

• [F80 Tetrahydrogestrinone.]

• Thiomesterone.

• Trenbolone.

(c) any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,

(i) by further substitution at position 17 by a methyl or ethyl group;

(ii) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(iii) by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv) by fusion of ring A with a heterocyclic system;

[F81 (ca ) 1–benzylpiperazine or any compound structurally derived from 1–benzylpiperazine or 1–phenylpiperazine by modification in any of the following ways—

(i) by substitution at the second nitrogen atom of the piperazine ring with alkyl, benzyl, haloalkyl or phenyl groups;

(ii) by substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy, halide or haloalkyl groups.]

(d) any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above F82 ...;

• (e) Chorionic Gonadotrophin (HCG).

• Clenbuterol.

• Non-human chorionic gonadotrophin.

• Somatotropin.

• Somatrem.

• Somatropin.

• [F83 Zeranol.]

• [F84 Zilpaterol.]]

Textual Amendments

F42 "(a)" inserted (1.9.1996) by S.I. 1996/1300, art. 2(2)(a)

F43 Word inserted by S.I. 1985/1995, art. 2(3)

F44 Words in Sch. 2 Pt. 3 para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(4)

F45 Word inserted by S.I. 1989/1340, art. 2(a)

F46 Word in Sch. 2 Pt. 3 para. 1(a) repealed (26.1.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2008 (S.I. 2008/3130), art. 2(3)(a)

F47 Words in Sch. 2 Pt. 3 para. 1(a) repealed (26.1.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2008 (S.I. 2008/3130), art. 2(3)(a)

F48 Words in Sch. 2 Pt. 3 para. 1(a) repealed (26.1.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2008 (S.I. 2008/3130), art. 2(3)(a)

F49 Word inserted by S.I. 1986/2230, art. 2(3)

F50 Word inserted by S.I. 1983/765, art. 2(a)

F51 Word inserted by S.I. 1984/859, art. 2(4)(a)

F52 Word in Sch. 2 Pt. 3 para. 1(a) inserted (23.12.2009 ) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(a)

F53 Word in Sch. 2 Pt. 3 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), arts. 1, 2(3)(a)

F54 Word in Sch. 2 Pt. 3 para. 1(a) inserted (1.1.2006) by The Misuse of Drugs Act 1971 (Amendment) Order 2005 (S.I. 2005/3178), art. 2

F55 Words repealed by S.I. 1973/771, art. 2

F56 Word repealed by S.I. 1984/859, art. 2(4)(a)

F57 Word inserted by S.I. 1990/2589, art. 2(b)

F58 Word inserted by S.I. 1989/1340, art. 2(b)

F59 Word in Sch. 2 Pt. 3 para.1 omitted (1.9.1995) by virtue of S.I. 1995/1966, art. 2

F60 Word in Sch. 2 Pt. 3 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), arts. 1, 2(3)(b)

F61 Sch. 2 Pt. 3 para. 1(b)-(e) added (1.9.1996) by S.I. 1996/1300, art. 2(2)(b)

F62 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(i)

F63 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(i)

F64 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(i)

F65 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(i)

F66 Word in Sch. 2 Pt. 3 para. 1(b) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), arts. 1, 2(4)(a)

F67 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(ii)

F68 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(iii)

F69 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(iv)

F70 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(v)

F71 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(v)

F72 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(vi)

F73 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(vi)

F74 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(vii)

F75 Word in Sch. 2 Pt. 3 para. 1(b) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), arts. 1, 2(4)(b)

F76 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(viii)

F77 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(ix)

F78 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(ix)

F79 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(x)

F80 Word in Sch. 2 Pt. 3 para. 1(b) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(b)(xi)

F81 Sch. 2 Pt. 3 para. 1(ca) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(c)

F82 Words in Sch. 2 Pt. 3 para. 1(d) repealed (26.1.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2008 (S.I. 2008/3130), art. 2(3)(b)

F83 Word in Sch. 2 Pt. 3 para. 1(e) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(d)

F84 Word in Sch. 2 Pt. 3 para. 1(e) inserted (23.12.2009) by The Misuse of Drugs Act 1971 (Amendment) Order 2009 (S.I. 2009/3209), art. 2(3)(d)

2 U.K. Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule [F85 not being phenylpropanolamine.]

Textual Amendments

F85 Words added by S.I. 1986/2230, art. 2(4)

3 U.K. Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.

4 U.K. Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule.

Part IV U.K. Meaning of certain Expressions used in this Schedule

For the purposes of this Schedule the following expressions (which are not among those defined in section 37(1) of this Act) have the meanings hereby assigned to them respectively, that is to say—

• “cannabinol derivatives” means the following substances, except where contained in cannabis or cannabis resin, namely tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives;

• “coca leaf” means the leaf of any plant of the genusErythroxylonfrom whose leaves cocaine can be extracted either directly or by chemical transformation;

• “concentrate of poppy-straw” means the material produced when poppy-straw has entered into a process for the concentration of its alkaloids;

• “medicinal opium” means raw opium which has undergone the process necessary to adapt it for medicinal use in accordance with the requirements of the British Pharmacopoeia, whether it is in the form of powder or is granulated or is in any other form, and whether it is or is not mixed with neutral substances;

• “opium poppy” means the plant of the speciesPapaver somniferum L;

• “poppy straw” means all parts, except the seeds, of the opium poppy, after mowing;

• “raw opium” includes powdered or granulated opium but does not include medicinal opium.